Or6c8, known as Olfr767, is an olfactory receptor (OR) in Mus musculus. It is part of the large and diverse family of G-protein-coupled receptors (GPCRs), which play a pivotal role in the perception of smells. These receptors are characterized by their 7-transmembrane domain structure, a feature they share with many neurotransmitter and hormone receptors. In the context of olfaction, these receptors are responsible for detecting odorant molecules in the nasal cavity and initiating a cascade of neuronal responses that culminate in the perception of a smell. The process begins when an odorant molecule binds to an OR like Olfr767, causing a conformational change in the receptor. This change activates an associated G-protein, which in turn triggers a series of intracellular events, leading to a neuronal response. The olfactory system, particularly in organisms like mice, is highly sophisticated and capable of discerning a vast array of odorants, with each receptor responding to specific molecules.
Inhibiting Olfr767, as with other ORs, presents a significant challenge. Direct inhibitors for these receptors are not commonly identified due to the specificity and vast diversity within the OR family. Therefore, the approach to inhibition often involves indirect methods, focusing on related pathways or processes within the olfactory signaling cascade. Considering that ORs are a subgroup of GPCRs, compounds that influence GPCR activity or downstream signaling pathways can potentially affect the function of Olfr767. For instance, beta-blockers, known for their role in inhibiting beta-adrenergic receptors, could indirectly modulate GPCR signaling pathways. This modulation might influence the signal transduction process of GPCRs, including olfactory receptors like Olfr767. However, the exact mechanisms and effects of these compounds on specific olfactory receptors are not directly established. The potential for these compounds to influence Olfr767 relies on their known actions on broader GPCR pathways, rather than on direct evidence of interaction with specific ORs. The complexity of GPCR signaling and the unique specificity of each OR mean that the indirect effects of these compounds are inferred and not definitively established. Thus, while these compounds offer potential routes for influencing Olfr767 activity, their precise impact on this receptor and the olfactory system at large is an area for further research and exploration.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol is a non-selective beta-adrenergic receptor antagonist. By inhibiting these receptors, it could indirectly modulate the GPCR signaling pathways, potentially altering the signal transduction of GPCRs including Olfr767 in olfactory neurons. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $124.00 $240.00 $530.00 $999.00 $1530.00 | 2 | |
Carvedilol serves as a non-selective beta-blocker with alpha-1 blocking activity. This may influence GPCR signaling, indirectly affecting the transduction process of GPCRs like Olfr767 by altering adrenergic receptor activity. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Yohimbine is an alpha-2 adrenergic receptor antagonist. It can modify adrenergic signaling pathways, potentially impacting GPCR function and indirectly influencing the efficiency of olfactory receptors like Olfr767. | ||||||
Labetalol | 36894-69-6 | sc-484723 | 50 mg | $180.00 | ||
Labetalol combines alpha and beta adrenergic blocking activities. This broad modulation of adrenergic signaling could indirectly affect GPCR signaling pathways, potentially influencing olfactory receptors like Olfr767. | ||||||
(S)-Timolol Maleate | 26921-17-5 | sc-203297 sc-203297A | 100 mg 250 mg | $61.00 $126.00 | ||
Timolol is a beta-adrenergic receptor antagonist that could indirectly affect GPCR signaling pathways, potentially influencing the signal transduction of olfactory receptors like Olfr767. | ||||||
Nadolol | 42200-33-9 | sc-253175 | 1 g | $184.00 | ||
As a non-selective beta-adrenergic receptor antagonist, Nadolol can indirectly modulate GPCR signaling pathways, potentially impacting the function of GPCRs like olfactory receptors. | ||||||
Sotalol hydrochloride | 959-24-0 | sc-203699 sc-203699A | 10 mg 50 mg | $68.00 $251.00 | 3 | |
Sotalol is a beta-blocker that may indirectly affect GPCR signaling, possibly influencing the transduction process in GPCRs such as olfactory receptors. | ||||||
Pindolol | 13523-86-9 | sc-204847 sc-204847A | 100 mg 1 g | $194.00 $760.00 | ||
Pindolol's non-selective beta-adrenergic antagonism might indirectly modulate GPCR signaling pathways, potentially affecting olfactory receptor functions. | ||||||
Metoprolol Tartrate | 56392-17-7 | sc-205751 sc-205751A | 5 g 25 g | $107.00 $243.00 | 3 | |
Metoprolol selectively blocks beta-1 adrenergic receptors, which could indirectly influence GPCR signaling mechanisms, affecting the activity of olfactory receptors. | ||||||
Esmolol | 81147-92-4 | sc-279019B sc-279019A sc-279019 | 50 mg 100 mg 500 mg | $100.00 $150.00 $650.00 | 1 | |
Esmolol's selective beta-1 adrenergic receptor antagonism can indirectly modulate GPCR signaling pathways, potentially influencing olfactory receptor function. | ||||||